Amgen Archives - Express Pharma

Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD: GlobalData

Lerodalcibep can be a treatment option for patients requiring additional LDL-C reduction: GlobalData

Amgen launches $200 million technology and innovation hub in Hyderabad

Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg

Amgen to open a new site in Hyderabad

USFDA grants approval of Bkemv to Amgen

Veeda Board appoints Dr Mahesh Bhalgat as Group CEO

Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData

Amgen says Lumakras cuts risk of lung cancer progression by 34 per cent